u 37883a has been researched along with cromakalim in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (41.67) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carroll, WA; Coghlan, MJ; Gopalakrishnan, M | 1 |
| Choe, E; Ferrara, J; Flint, L; Franklin, E; Grivas, T; Hyman, A; Lippton, H | 1 |
| Khan, SA; Meisheri, KD; Ohrnberger, CE | 1 |
| Cipkus-Dubray, LA; Humphrey, SJ; Jones, AW; Khan, SA; Meisheri, KD; Smith, MP | 1 |
| Anwar, M; Banister, RE; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD | 1 |
| Barrett-Jolley, R; Everitt, D; Köppel, H; Quayle, JM; Wellman, GC | 1 |
| Anwar, M; De Witt, BJ; Feng, CJ; Kadowitz, PJ; Kaye, AD; Nossaman, BD; Smith, DE | 1 |
| Ikeda, S; Kyotani, S; Min, KY; Mori, H; Nagaya, N; Nakanishi, N; Ninomiya, I; Oya, H; Shimouchi, A; Shirai, M | 1 |
| Bivalacqua, TJ; Champion, HC; Coy, DH; Kadowitz, PJ; Murphy, WA; Pierce, RL | 1 |
| Ito, Y; Naito, S; Teramoto, N; Tomoda, T; Yunoki, T | 1 |
| Al Abed, A; Brock, JA; Tan, JH | 1 |
| Baun, M; Boni, LJ; Hay-Schmidt, A; Jansen-Olesen, I; Olesen, J; Ploug, KB | 1 |
1 review(s) available for u 37883a and cromakalim
| Article | Year |
|---|---|
Recent developments in the biology and medicinal chemistry of potassium channel modulators: update from a decade of progress.
Topics: Adenosine Triphosphate; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Calcium; Ion Channel Gating; Myocardial Ischemia; Potassium Channel Blockers; Potassium Channels; Urinary Incontinence | 2001 |
11 other study(ies) available for u 37883a and cromakalim
| Article | Year |
|---|---|
Femoral vasodilation to cromakalim is blocked by U37883A, a non-sulphonylurea that selectively inhibits KATP channels.
Topics: Adamantane; Analysis of Variance; Animals; Benzopyrans; Cromakalim; Dogs; Drug Interactions; Femur; Injections, Intravenous; Isoproterenol; Morpholines; Nitroglycerin; Potassium Channels; Pyrroles; Regional Blood Flow; Serotonin; Serotonin Receptor Agonists; Vasodilation; Vasodilator Agents | 1995 |
Synergistic effects of glyburide and U-37883A, two structurally different vascular ATP-sensitive potassium channel antagonists.
Topics: Adamantane; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Drug Synergism; Gallopamil; Glyburide; In Vitro Techniques; Ion Channel Gating; Male; Mesenteric Arteries; Minoxidil; Morpholines; Potassium Channels; Pyrroles; Rabbits; Vasodilation | 1993 |
4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.
Topics: Adamantane; Adenosine Triphosphate; Animals; Benzopyrans; Blood Pressure; Cats; Cromakalim; Dogs; Female; In Vitro Techniques; Male; Mesenteric Arteries; Minoxidil; Morpholines; Potassium; Potassium Channels; Pyrroles; Rabbits; Rats; Rats, Sprague-Dawley; Vasodilation | 1993 |
Pulmonary vasodilation by ketamine is mediated in part by L-type calcium channels.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Anesthetics, Dissociative; Animals; Arachidonic Acid; Arginine; Blood Pressure; Calcium Channel Blockers; Calcium Channels; Cromakalim; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Ketamine; Lung; Male; Meclofenamic Acid; Morpholines; Potassium Channels; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Vasodilation; Verapamil | 1998 |
Inhibition of vascular K(ATP) channels by U-37883A: a comparison with cardiac and skeletal muscle.
Topics: Adamantane; Adenosine Triphosphate; Animals; Cromakalim; In Vitro Techniques; Male; Mesenteric Arteries; Morpholines; Muscle Relaxation; Muscle, Skeletal; Myocardium; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Rats; Rats, Wistar | 1999 |
Analysis of responses of garlic derivatives in the pulmonary vascular bed of the rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adamantane; Allyl Compounds; Animals; Antihypertensive Agents; Antioxidants; Bronchodilator Agents; Cromakalim; Cyclooxygenase Inhibitors; Disulfides; Diuretics; Enzyme Inhibitors; Garlic; Hypertension, Pulmonary; Lung Diseases, Obstructive; Male; Meclofenamic Acid; Morpholines; NG-Nitroarginine Methyl Ester; Plants, Medicinal; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Respiration; Sulfhydryl Compounds; Sulfinic Acids; Vasoconstrictor Agents | 2000 |
K(ATP) channels predominantly regulate conduit vessel tone in normoxic cat pulmonary arteries in vivo.
Topics: Adamantane; Adenosine Triphosphate; Animals; Blood Pressure; Cats; Cromakalim; Dose-Response Relationship, Drug; Glyburide; Morpholines; Potassium Channels; Pulmonary Artery; Vasoconstriction; Vasodilator Agents | 2001 |
Analysis of responses to hAmylin, hCGRP, and hADM in isolated resistance arteries from the mesenteric vascular bed of the rat.
Topics: Acetylcholine; Adamantane; Adrenomedullin; Amyloid; Animals; Arginine; Calcitonin Gene-Related Peptide; Cromakalim; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Humans; In Vitro Techniques; Islet Amyloid Polypeptide; Mesenteric Arteries; Morpholines; Nitric Oxide Synthase; Oxadiazoles; Peptide Fragments; Peptides; Perfusion; Potassium Channel Blockers; Quinoxalines; Rats; Receptors, Calcitonin Gene-Related Peptide; Receptors, Islet Amyloid Polypeptide; Receptors, Peptide; Vascular Resistance; Vasodilator Agents | 2001 |
Multiple actions of U-37883A, an ATP-sensitive K+ channel blocker, on membrane currents in pig urethra.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Adamantane; Adenosine Triphosphate; Analysis of Variance; Animals; Barium; Calcium Channel Agonists; Cromakalim; Dose-Response Relationship, Drug; Female; Glyburide; In Vitro Techniques; Membrane Potentials; Morpholines; Muscle Cells; Nitroprusside; Patch-Clamp Techniques; Potassium Channel Blockers; Potassium Channels, Inwardly Rectifying; Swine; Time Factors; Urethra; Vasodilator Agents | 2005 |
Inhibition of KATP channels in the rat tail artery by neurally released noradrenaline acting on postjunctional alpha2-adrenoceptors.
Topics: Adamantane; Adenosine Triphosphate; Animals; Arteries; Calcitonin Gene-Related Peptide; Cromakalim; Dose-Response Relationship, Drug; Electric Impedance; Excitatory Postsynaptic Potentials; Female; Glyburide; In Vitro Techniques; Ion Channel Gating; Morpholines; Muscle, Smooth, Vascular; Norepinephrine; Pinacidil; Potassium Channel Blockers; Potassium Channels; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Sympathetic Nervous System; Tail; Time Factors | 2007 |
K(ATP) channel expression and pharmacological in vivo and in vitro studies of the K(ATP) channel blocker PNU-37883A in rat middle meningeal arteries.
Topics: Adamantane; Animals; ATP-Binding Cassette Transporters; Blotting, Western; Cromakalim; Data Interpretation, Statistical; Diuretics; Guanidines; In Vitro Techniques; KATP Channels; Male; Meningeal Arteries; Microscopy, Video; Morpholines; Multidrug Resistance-Associated Proteins; Pinacidil; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Drug; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonylurea Receptors; Vasodilator Agents | 2008 |